№ lp_2_3_22307
File format: docx Character count: 41048 File size: 158 KB
Year: 2023
Region / City: England, Northern Ireland
Topic: Mental Health, Epilepsy, Psychological Therapy
Document Type: Clinical Trial Report
Organization: UCL Great Ormond Street Institute of Child Health
Author: Sophie D. Bennett, J. Helen Cross, Kashfia Chowdhury, Tamsin Ford, Isobel Heyman, Anna E. Coughtrey, Emma Dalrymple, Sarah Byford, Bruce Chorpita, Peter Fonagy, Rona Moss-Morris, Colin Reilly, Jonathan A. Smith, Terence Stephenson, Sophia Varadkar, James Blackstone, Harriet Quartly, Tyler Hughes, Amy Lewins, Elana Moore, Fahreen Walji, Alice Welch, Emily Whelan, Alice Zacharia, Anais D’Oelsnitz, Mariam Shah, Laila Xu, Aikaterini Vezyroglou, Kirsten Mitchell, Isabella E. Nizza, Poushali Ganguli, Roz Shafran
Target Audience: Researchers, Clinicians, Policy Makers, Families
Period of Action: August 2019 – February 2022
Approval Date: Not specified
Date of Changes: Not specified
Summary: Randomised controlled trial assessing the effectiveness of the Mental Health Intervention for Children with Epilepsy (MICE) in treating mental health difficulties in children and young people with epilepsy, alongside usual care.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Safety Reporting for SUSARs, SSIs, and Multi-centre Applications
Note: Year
The STOP-ACEi Trial: A multi-centre Randomised Controlled Trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced renal disease.
Year: 2013
Region / City: Leeds, Yorkshire and The Humber
Theme: Clinical trials, Chronic Kidney Disease
Document type: Research study protocol
Organization: University of Birmingham Clinical Trials Unit, Hull and East Yorkshire Hospitals NHS Trust
Author: Prof Sunil Bhandari
Target audience: Healthcare professionals, nephrologists, researchers
Period of validity: 3 years
Approval date: 2013
Change date: N/A
Study reference number: 11/30/07
Ethics committee reference: 13/YH/0394
EudraCT number: 2013-003798-82
Sponsor: Hull and East Yorkshire Hospitals NHS Trust
Funding source: Efficacy and Mechanism Evaluation (EME) programme, National Institute for Health Research (NIHR), Medical Research Council (MRC)
Note: Contextual description
Usual and Customary Contact Lens Fitting Fees (Elective & VNCL), Effective XX-XX-XXXX
Year: Not specified
Region / Location: Not specified
Subject: Contact lens fitting fees and VSP compliance requirements
Document type: Fee schedule and compliance guidelines
Clinical levels: Level 1–6 contact lens fitting complexity
Billing codes: 92310, 92313, 92071, 92072, V2530, V2531, V2599
Lens types: Soft contact lenses, gas permeable, scleral, keratoconus, hybrid, multifocal
Fee structure: Diagnostic fitting, new fit, refit, routine progress evaluation
Insurance program: VSP, VNCL
Follow-up period: 90 days
Effective date: XX-XX-XXXX
Source category: Clinical administrative documentation
Application for Teaching Development Grants (for both usual and collaborative TDG projects)
Note: Year
Supplementary Table 2. Changes in Peak Exercise Parameters for Usual Care and Exercise Trained Groups at 4 and 16 Months
Study context: Patients undergoing anthracycline chemotherapy
Comparison groups: Usual Care; Exercise Trained
Baseline reference: Pre-AC (before anthracycline chemotherapy)
Follow-up periods: 4 months; 16 months
Outcome measures: VO2peak (mL/kg/min); Peak Watts (W); HRpeak (bpm); SVpeak (mL); Qcpeak (L/min); a-vO2 diff (%)
Statistical reporting: Unadjusted mean ± SD at baseline; unadjusted mean (95% CI) for change from baseline; unadjusted mean (95% CI) net difference between groups
Adjustment factors: P-values adjusted for age and baseline values
Measurement method: Peak stroke volume measured during exercise CMR
Abbreviations: AC (anthracycline chemotherapy); HR (heart rate); SV (stroke volume); Qc (cardiac output); a-vO2 diff (arterio-venous oxygen difference)
Type of source: Supplementary scientific data table
Topics: assessment-enhanced Multi-centre Usual